查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1604729

心房中膈缺损症市场：依症状、依应用分类 - 2025-2030 年全球预测

Atrial Septal Defect Market by Symptoms (Dyspnea, Fatigue, Frequent Respiratory Infections), Application (Ambulatory Surgical Centers, Hospitals, Specialty Clinics) - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 196 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

2023年心房中膈缺损症市场价值为57亿美元，预计到2024年将达到60.5亿美元，复合年增长率为6.29%，到2030年将达到87.3亿美元。

心房中膈缺损症（ASD）是一种先天性心臟结构异常，其特征是房间隔上有一个洞，导致血液在左右心房之间流动。自闭症谱系障碍 (ASD) 治疗的需要源于疲劳、呼吸短促等症状，以及如果不治疗则有中风和心臟衰竭等併发症的风险。最终用途包括微创手术、基于导管的干预措施和设备植入，包括医院、门诊外科中心和心臟诊所。市场成长的推动因素包括意识和诊断率的提高、外科手术技术的进步以及易患心臟病的老年人口的增加。主要商机在医疗基础设施不断改善、医疗保健支出不断增加的新兴市场。此外，生物分解性植入和机器人辅助手术系统的进步是一个有前景的投资和创新领域。然而，市场面临着手术成本上升、低收入地区的准入有限、后勤复杂性以及术后併发症的可能性等挑战，导致需要具有成本效益的干预措施和医疗保健提供者，这表明需要改进培训。此外，监管挑战和对植入技术进行严格临床检验的需求可能会阻碍新产品快速进入市场。非侵入性诊断技术的创新、使用人工智慧的个人化治疗计划以及开发具有成本效益的治疗方法为研究和业务成长提供了重要途径。总体而言，自闭症谱系障碍治疗市场是一个竞争激烈但前景广阔的市场，越来越重视早期诊断和早期疗育，并且在改善患者治疗效果、可负担性和可及性方面具有巨大的创新空间，您可以说这是一个市场。公司可以透过重视与医疗保健提供者的策略伙伴关係关係并投资于突破性技术的研发来维持并最大限度地发挥其成长潜力。

主要市场统计
基准年[2023] 57亿美元
预计年份 [2024] 60.5亿美元
预测年份 [2030] 87.3亿美元
复合年增长率（%） 6.29%

市场动态：快速发展的心房中膈缺损症市场的关键市场洞察

心房中膈缺损症市场正因供需的动态交互作用而转变。了解这些不断变化的市场动态可以帮助企业做出明智的投资决策、策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，同时也能帮助企业了解消费行为及其对製造业的影响。

  • 市场驱动因素
    • 遗传性心臟疾病盛行率上升
    • 政府和公共机构加强对心房中膈缺损症的认知宣传活动
    • 采用心臟 MRI
  • 市场限制因素
    • 经皮缺损封堵术的解剖学局限性
  • 市场机会
    • 先天性心臟疾病治疗技术进展
    • 政府对 ASD 治疗给予优惠报销
  • 市场挑战
    • ASD 手术期间的併发症和副作用

波特五力：驾驭心房中膈缺损症市场的策略工具

波特的五力框架是了解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解心房中膈缺损症市场的外部影响

外部宏观环境因素在塑造心房中膈缺损症市场的绩效动态方面发挥关键作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解心房中膈缺损症市场的竞争格局

心房中膈缺损症市场的详细市场占有率分析可以对供应商的绩效进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示其竞争地位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV 定位矩阵心房中膈缺损症市场供应商的绩效评估

FPNV 定位矩阵是评估心房中膈缺损症市场供应商的关键工具。此矩阵允许业务组织根据商务策略和产品满意度评估供应商，从而做出与其目标相符的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析和建议绘製心房中膈缺损症市场的成功之路

对于想要加强在全球市场的影响力的公司来说，对心房中膈缺损症市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：详细检视当前市场环境、主要企业的广泛资料、评估其在市场中的影响力和整体影响力。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 遗传性心臟病的发生率增加
      • 政府和公共机构扩大对心房中膈缺损症的认知宣传活动
      • 心臟MRI检查简介
    • 抑制因素
      • 经皮缺损封堵术的解剖学局限性
    • 机会
      • 先天性心臟疾病治疗技术进展
      • 政府对 ASD 治疗给予优惠报销
    • 任务
      • ASD 手术期间的併发症和副作用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章心房中膈缺损症市场（依症状）

  • 呼吸困难
  • 疲劳
  • 频繁呼吸道感染疾病
  • 心悸
  • 腿和脚肿胀

第七章心房中膈缺损症市场：依应用分类

  • 门诊手术中心
  • 医院
  • 专科诊所

第八章 北美和南美心房中膈缺损症市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第九章亚太房心房中膈缺损症市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十章欧洲、中东和非洲心房中膈缺损症市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十一章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • Abbott Laboratories
  • Asklepion Pharmaceuticals, LLC
  • AtriCure, Inc
  • Carag AG
  • GE HealthCare Technologies, Inc.
  • Johnson & Johnson Services, Inc.
  • Lepu Medical Technology（Beijing）Co., Ltd
  • Lifetech Scientific
  • Medtronic PLC
  • Occlutech GmbH
  • Siemens AG
  • WL Gore & Associates, Inc.
Product Code: MRR-CA17E905E9C1

The Atrial Septal Defect Market was valued at USD 5.70 billion in 2023, expected to reach USD 6.05 billion in 2024, and is projected to grow at a CAGR of 6.29%, to USD 8.73 billion by 2030.

Atrial Septal Defect (ASD) is a congenital structural heart defect characterized by a hole in the atrial septum, allowing blood to flow between the left and right atria. The necessity for ASD treatments stems from symptoms like fatigue, shortness of breath, and risk of complications such as stroke or heart failure in untreated cases. Applications include minimally invasive surgical procedures, catheter-based interventions, and device implants, with end-use sectors such as hospitals, outpatient surgical centers, and specialty cardiac clinics. Market growth is fueled by increasing awareness and diagnosis rates, technological advancements in surgical techniques, and a growing geriatric population susceptible to heart defects. Key opportunities lie in emerging markets with improving healthcare infrastructure and increasing healthcare expenditure. Additionally, advancements in biodegradable implants and robotic-assisted surgery systems represent promising areas for investment and innovation. However, the market faces challenges including high costs of procedures, limited accessibility in low-income regions, logistical complexities, and potential post-operative complications, suggesting the need for cost-effective interventions and improved training for healthcare professionals. Moreover, regulatory challenges and the need for rigorous clinical validation in implant technologies can impede rapid market entry of new products. Innovations in non-invasive diagnostic techniques, personalized treatment plans using artificial intelligence, and the development of cost-efficient therapeutic treatments offer significant avenues for research and business growth. Overall, the ASD treatment market demonstrates a competitive yet promising landscape, driven by an increasing emphasis on early diagnosis and intervention, with substantial room for technological innovation to enhance patient outcomes, affordability, and accessibility. Businesses should focus on strategic partnerships with healthcare providers and invest in R&D for breakthrough technologies to sustain and maximize growth potential.

KEY MARKET STATISTICS
Base Year [2023] USD 5.70 billion
Estimated Year [2024] USD 6.05 billion
Forecast Year [2030] USD 8.73 billion
CAGR (%) 6.29%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Atrial Septal Defect Market

The Atrial Septal Defect Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising prevalences of genetic heart disorders
    • Growing awareness campaigns regarding atrial septal defects by government and public organizations
    • Adoption of cardiac MRI procedures
  • Market Restraints
    • Anatomical limitations to percutaneous ASD closure
  • Market Opportunities
    • Technological advancement in the treatment of congenital heart diseases
    • Favorable government reimbursements for ASD treatment
  • Market Challenges
    • Complication and side effects during ASD surgeries

Porter's Five Forces: A Strategic Tool for Navigating the Atrial Septal Defect Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Atrial Septal Defect Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Atrial Septal Defect Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Atrial Septal Defect Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Atrial Septal Defect Market

A detailed market share analysis in the Atrial Septal Defect Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Atrial Septal Defect Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Atrial Septal Defect Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Atrial Septal Defect Market

A strategic analysis of the Atrial Septal Defect Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Atrial Septal Defect Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Asklepion Pharmaceuticals, LLC, AtriCure, Inc, Carag AG, GE HealthCare Technologies, Inc., Johnson & Johnson Services, Inc., Lepu Medical Technology (Beijing) Co., Ltd, Lifetech Scientific, Medtronic PLC, Occlutech GmbH, Siemens AG, and W. L. Gore & Associates, Inc..

Market Segmentation & Coverage

This research report categorizes the Atrial Septal Defect Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Symptoms, market is studied across Dyspnea, Fatigue, Frequent Respiratory Infections, Heart Palpitations, and Swelling of Legs & Feet.
  • Based on Application, market is studied across Ambulatory Surgical Centers, Hospitals, and Specialty Clinics.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising prevalences of genetic heart disorders
      • 5.1.1.2. Growing awareness campaigns regarding atrial septal defects by government and public organizations
      • 5.1.1.3. Adoption of cardiac MRI procedures
    • 5.1.2. Restraints
      • 5.1.2.1. Anatomical limitations to percutaneous ASD closure
    • 5.1.3. Opportunities
      • 5.1.3.1. Technological advancement in the treatment of congenital heart diseases
      • 5.1.3.2. Favorable government reimbursements for ASD treatment
    • 5.1.4. Challenges
      • 5.1.4.1. Complication and side effects during ASD surgeries
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Atrial Septal Defect Market, by Symptoms

  • 6.1. Introduction
  • 6.2. Dyspnea
  • 6.3. Fatigue
  • 6.4. Frequent Respiratory Infections
  • 6.5. Heart Palpitations
  • 6.6. Swelling of Legs & Feet

7. Atrial Septal Defect Market, by Application

  • 7.1. Introduction
  • 7.2. Ambulatory Surgical Centers
  • 7.3. Hospitals
  • 7.4. Specialty Clinics

8. Americas Atrial Septal Defect Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Atrial Septal Defect Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Atrial Septal Defect Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. Market Share Analysis, 2023
  • 11.2. FPNV Positioning Matrix, 2023
  • 11.3. Competitive Scenario Analysis
  • 11.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Abbott Laboratories
  • 2. Asklepion Pharmaceuticals, LLC
  • 3. AtriCure, Inc
  • 4. Carag AG
  • 5. GE HealthCare Technologies, Inc.
  • 6. Johnson & Johnson Services, Inc.
  • 7. Lepu Medical Technology (Beijing) Co., Ltd
  • 8. Lifetech Scientific
  • 9. Medtronic PLC
  • 10. Occlutech GmbH
  • 11. Siemens AG
  • 12. W. L. Gore & Associates, Inc.

LIST OF FIGURES

  • FIGURE 1. ATRIAL SEPTAL DEFECT MARKET RESEARCH PROCESS
  • FIGURE 2. ATRIAL SEPTAL DEFECT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 11. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 13. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ATRIAL SEPTAL DEFECT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 19. ATRIAL SEPTAL DEFECT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. ATRIAL SEPTAL DEFECT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. ATRIAL SEPTAL DEFECT MARKET DYNAMICS
  • TABLE 7. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY DYSPNEA, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY FATIGUE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY FREQUENT RESPIRATORY INFECTIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY HEART PALPITATIONS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SWELLING OF LEGS & FEET, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 18. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 20. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 21. ARGENTINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 23. BRAZIL ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 25. CANADA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 26. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 27. MEXICO ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 28. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 29. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. UNITED STATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 31. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 32. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 33. ASIA-PACIFIC ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 34. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 35. AUSTRALIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 37. CHINA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 39. INDIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. INDONESIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 41. INDONESIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 43. JAPAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. MALAYSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 45. MALAYSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. PHILIPPINES ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 47. PHILIPPINES ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. SINGAPORE ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 49. SINGAPORE ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 51. SOUTH KOREA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. TAIWAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 53. TAIWAN ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. THAILAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 55. THAILAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 56. VIETNAM ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 57. VIETNAM ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 58. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 59. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 60. EUROPE, MIDDLE EAST & AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 61. DENMARK ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 62. DENMARK ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. EGYPT ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 64. EGYPT ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. FINLAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 66. FINLAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 68. FRANCE ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 70. GERMANY ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. ISRAEL ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 72. ISRAEL ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 74. ITALY ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. NETHERLANDS ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 76. NETHERLANDS ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. NIGERIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 78. NIGERIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. NORWAY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 80. NORWAY ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. POLAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 82. POLAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. QATAR ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 84. QATAR ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 86. RUSSIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SAUDI ARABIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 88. SAUDI ARABIA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 90. SOUTH AFRICA ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 92. SPAIN ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. SWEDEN ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 94. SWEDEN ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. SWITZERLAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 96. SWITZERLAND ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. TURKEY ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 98. TURKEY ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 99. UNITED ARAB EMIRATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 100. UNITED ARAB EMIRATES ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 101. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY SYMPTOMS, 2018-2030 (USD MILLION)
  • TABLE 102. UNITED KINGDOM ATRIAL SEPTAL DEFECT MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 103. ATRIAL SEPTAL DEFECT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 104. ATRIAL SEPTAL DEFECT MARKET, FPNV POSITIONING MATRIX, 2023